A federal appeals court found that a U.S. Patent Office board erred in its legal analysis of the challenge to Medtronic’s neurostimulation patents.
A federal appeals court found that a U.S. Patent Office board erred in its legal analysis of the challenge to Medtronic’s neurostimulation patents.